These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 24100806)

  • 1. Interferon γ-release assays for diagnosis of latent tuberculosis in healthcare workers in low-incidence settings: pros and cons.
    Pollock NR; McAdam AJ; Pai M; Nardell EA; Bernardo J; Banaei N; Mobo J
    Clin Chem; 2014 May; 60(5):714-8. PubMed ID: 24100806
    [No Abstract]   [Full Text] [Related]  

  • 2. Improving T-cell assays for diagnosis of latent TB infection: Confirmation of the potential role of testing Interleukin-2 release in Iranian patients.
    Mamishi S; Pourakbari B; Shams H; Marjani M; Mahmoudi S
    Allergol Immunopathol (Madr); 2016; 44(4):314-21. PubMed ID: 26786720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of latent tuberculosis infection among healthcare workers in China as detected by two interferon-gamma release assays.
    Wei Z; Yang M; Quan B; Wang Y; Wu Y; Ji B
    J Hosp Infect; 2013 Aug; 84(4):323-5. PubMed ID: 23806839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of interferon gamma release assay to assess latent tuberculosis infection among healthcare workers in Hong Kong.
    Tsang DN; Lai CK; Yam WC; Chan JW; Mok YW; Seto WH; Fung SC; Chu CM; Lam BH; Ng TK
    Hong Kong Med J; 2015 Dec; 21 Suppl 7():S22-5. PubMed ID: 26908269
    [No Abstract]   [Full Text] [Related]  

  • 5. Testing for latent tuberculosis infection using interferon gamma release assays in commercial sex workers at an outreach clinic in Birmingham.
    Daly R; Khatib N; Larkins A; Dedicoat M
    Int J STD AIDS; 2016 Jul; 27(8):676-9. PubMed ID: 26589629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating granulysin levels in healthcare workers and latent tuberculosis infection estimated using interferon-gamma release assays.
    Thuong PH; Tam DB; Sakurada S; Hang NT; Hijikata M; Hong LT; Ngoc PT; Anh PT; Cuong VC; Matsushita I; Lien LT; Keicho N
    BMC Infect Dis; 2016 Oct; 16(1):580. PubMed ID: 27756230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon-γ release assay as a sensitive diagnostic tool of latent tuberculosis infection in patients with HIV: a cross-sectional study.
    Klautau GB; da Mota NVF; Salles MJC; Burattini MN; Rodrigues DS
    BMC Infect Dis; 2018 Nov; 18(1):585. PubMed ID: 30453903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. False-positive quantiferon results at a large healthcare institution.
    Slater M; Dubose A; Banaei N
    Clin Infect Dis; 2014 Jun; 58(11):1641-2. PubMed ID: 24610428
    [No Abstract]   [Full Text] [Related]  

  • 9. Interferon gamma release assays and the NICE 2011 guidelines on the diagnosis of latent tuberculosis.
    Mujakperuo HR; Thompson RD; Thickett DR
    Clin Med (Lond); 2013 Aug; 13(4):362-6. PubMed ID: 23908505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon gamma release assay (QuantiFERON-TB Gold In Tube) in patients of sarcoidosis from a population with high prevalence of tuberculosis infection.
    Gupta D; Kumar S; Aggarwal AN; Verma I; Agarwal R
    Sarcoidosis Vasc Diffuse Lung Dis; 2011 Oct; 28(2):95-101. PubMed ID: 22117500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 'Management of a tuberculosis exposure in the immunocompromised setting - are the NICE guidelines adequate?'.
    O'Leary MJ; O'Connor TM; O'Reilly S
    Clin Med (Lond); 2013 Dec; 13(6):632. PubMed ID: 24298124
    [No Abstract]   [Full Text] [Related]  

  • 12. Prospective comparison of tuberculin skin test and QuantiFERON-TB Gold In-Tube assay for the detection of latent tuberculosis infection among healthcare workers in a low-incidence setting.
    Cummings KJ; Smith TS; Shogren ES; Khakoo R; Nanda S; Bunner L; Smithmyer A; Soccorsi D; Kashon ML; Mazurek GH; Friedman LN; Weissman DN
    Infect Control Hosp Epidemiol; 2009 Nov; 30(11):1123-6. PubMed ID: 19803719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Interferon-Gamma Release Assays in the diagnosis of latent tuberculosis infection in clinical situations].
    Borkowska D; Radzikowska E; Załęska J; Ziołkowski J; Klatt M; Zwolska Z; Augustynowicz-Kopeć E; Roszkowski-Śliż K
    Pneumonol Alergol Pol; 2014; 82(1):39-45. PubMed ID: 24391070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Practice recommendations for the use and interpretation of interferon gamma release assays in the diagnosis of latent and active tuberculosis].
    Bergot E; Abiteboul D; Andréjak C; Antoun F; Barras E; Blanc FX; Bourgarit A; Charlois-Ou C; Delacourt C; Dirou S; Gerin M; Guerin S; Haustraete É; Henry B; Lucet JC; Maitre T; Morin J; Le Palud P; Pommelet V; Rivoisy C; Robert J; Veziris N; Herrmann JL
    Rev Mal Respir; 2018 Oct; 35(8):852-858. PubMed ID: 30224215
    [No Abstract]   [Full Text] [Related]  

  • 15. Interferon-gamma release assay: use and misuse.
    Brouqui P; Delaigue S; Parola P; Drancourt M
    Clin Microbiol Infect; 2012 Nov; 18(11):1053-4. PubMed ID: 23020675
    [No Abstract]   [Full Text] [Related]  

  • 16. Estimating Latent Tuberculosis Infection Using Interferon-γ Release Assay, Japan.
    Nishimura T; Ota M; Mori M; Hasegawa N; Kawabe H; Kato S
    Emerg Infect Dis; 2018 Nov; 24(11):2111-2113. PubMed ID: 30334726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevalence of latent infection with Mycobacterium tuberculosis in Mazovia Region using interferon gamma release assay after stimulation with specific antigens ESAT-6 and CFP-10].
    Kuś J; Demkow U; Lewandowska K; Korzeniewska-Koseła M; Rabczenko D; Siemion-Szcześniak I; Białas-Chromiec B; Bychawska M; Sapigórski P; Maciejewski J
    Pneumonol Alergol Pol; 2011; 79(6):407-18. PubMed ID: 22028119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon Gamma Release Assays to Diagnose Latent Tuberculosis Infection in Pediatric Dialysis Patients.
    Cruz AT; Geer JJ; Sarasak GM; Swartz SJ
    J Pediatric Infect Dis Soc; 2015 Mar; 4(1):84-6. PubMed ID: 26407367
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevalence of latent tuberculosis infection in BCG-vaccinated healthcare workers by using an interferon-gamma release assay and the tuberculin skin test in an intermediate tuberculosis burden country.
    Hung WT; Lee SS; Sy CL; Wu KS; Chen JK; Tsai HC; Chen YS
    J Microbiol Immunol Infect; 2015 Apr; 48(2):147-52. PubMed ID: 24071516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon-γ release assays versus tuberculin skin test for targeting people for tuberculosis preventive treatment: an evidence-based review.
    Muñoz L; Santin M
    J Infect; 2013 Apr; 66(4):381-7. PubMed ID: 23298892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.